Before we tackle this question, it is important to define mental well-being, which, in a clinical setting, can be determined through the use of biomarkers in conjunction with analyses of behavior and symptoms. Mental disorders such as depression, alongside anxiety and other conditions, have been particularly prevalent during the Covid-19 pandemic, with rates of depression increasing by up to 25% worldwide (World Health Organization). Depression and anxiety, which cause a “persistent feeling of sadness and loss of interest” (Khan), have been attributed to imbalances in certain biomarkers as well as psychosocial factors, those being mainly the monoamine group of neurotransmitters (dopamine, norepinephrine, and serotonin) and stress hormones such as cortisol and alpha-amylase (Humer et al.). The influence of lifestyle factors, including diet, stress, and physical activity, have been studied rigorously in the scientific literature, with the current consensus pointing towards an abundance of benefits attributed to exercise itself.